CervoMed Inc. Convertible Notes Payable, Current
CervoMed Inc. (CRVO) had Convertible Notes Payable, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2024-03-29
- 2023-12-31: Convertible Notes Payable, Current $0.00.
- 2023-09-30: Convertible Notes Payable, Current $0.00.
- 2022-12-31: Convertible Notes Payable, Current $12.41M.
- 2017-12-31: Convertible Notes Payable, Current $550.00K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-29 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2022-12-31 | $12.41M 10-K · filed 2024-03-29 |
| 2017-12-31 | $550.00K 10-K · filed 2019-03-19 |
| 2017-09-30 | $550.00K 10-Q · filed 2017-11-13 |
| 2017-03-31 | $1.88M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.88M 10-K · filed 2018-04-02 |
| 2015-12-31 | $424.96K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |